Effects of combined immunosuppressant and hepatitis B virus antiviral use on COVID-19 vaccination in recipients of living donor liver transplantation
PeerJ · 2024
DOI: 10.7717/peerj.18651 ↗Kurz gefasst
Fachartikel in der Zeitschrift PeerJ, 2024. Verfasst von Ryunjin Lee und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Convergence Medicine, Asan Medical Institute of Convergence Science and Technology (AMIST), Seoul, Republic of South Korea. Hauptthemen laut MEDLINE: Liver Transplantation, Immunosuppressive Agents, COVID-19, Antiviral Agents. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea.
Abstract (Originalsprache)
Background & Aims The global pandemic caused by the highly contagious SARS-CoV-2 virus led to the emergency approval of COVID-19 vaccines to reduce rising morbidity and mortality. However, limited research exists on evaluating the impact of these vaccines on immunocompromised individuals, such as recipients of living donor liver transplantation, highlighting the need for further studies to better understand their effectiveness in this specific population.
Methods
From June 2021, we followed up on the effectiveness of the vaccine for patients taking immunosuppressive drugs after living-donor liver transplantation (LDLT). A total of 105 immunocompromised individuals participated, of which 50 patients with hepatitis B were taking antiviral drugs. Patients were assessed to analyze how the combination of immunosuppressive and antiviral drugs affected the efficacy of the BNT162b2, mRNA-1273, and ChAdOx1 nCoV-19 COVID-19 vaccines.
Results
Before and after the vaccinations, patients were monitored to establish differences between immunosuppressed patients and those additionally taking antiviral drugs. In immunocompromised patients taking antiviral drugs for hepatitis B, we confirmed that the effect of the COVID-19 vaccine was reduced when compared to immunocompromised patients. Interestingly, 23 patients (11 without and 12 additionally with hepatitis B drug administration) encountered breakthrough infections, and although there was a minor discrepancy in vaccine efficacy among the patients taking antiviral drugs for hepatitis B, it did not reach statistical significance.
Conclusions
Additional COVID-19 vaccination is recommended for patients taking immunosuppressive drugs and hepatitis B antiviral drugs after LDLT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Convergence Medicine, Asan Medical Institute of Convergence Science and Technology (AMIST), Seoul, Republic of South Korea.
- Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of South Korea.
- Division of Hepatobiliary Surgery and Liver Transplantation, Seoul, Republic of South Korea.
- Division of Pediatric Surgery, Department of Surgery, Asan Medical Center, University Ulsan College of Medicine, Seoul, Republic of South Korea.
ORCID-Profile: Jiwan Choi, Jooyoung Lee, Jiye Kim
Förderung
- National Research Foundation of Korea
- Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea
Zitieren
APA
Lee, R., Choi, J., Lee, E., Lee, J., Kim, J., Kang, S., An, H. I., Kim, S. H., Kim, S. M., Jwa, E. K., Park, G. C., Namgoong, J. M., Song, G. W., Yoon, Y. I., Tak, E., & Lee, S. G. (2024). Effects of combined immunosuppressant and hepatitis B virus antiviral use on COVID-19 vaccination in recipients of living donor liver transplantation. PeerJ. https://doi.org/10.7717/peerj.18651
Vancouver
Lee R, Choi J, Lee E, Lee J, Kim J, Kang S, et al. Effects of combined immunosuppressant and hepatitis B virus antiviral use on COVID-19 vaccination in recipients of living donor liver transplantation. PeerJ. 2024. doi:10.7717/peerj.18651
BibTeX
@article{Lee2024,
author = {Lee, Ryunjin and Choi, Jiwan and Lee, Eunkyeong and Lee, Jooyoung and Kim, Jiye and Kang, Seoon and An, Hye-In and Kim, Sung-Han and Kim, Sung-Min and Jwa, Eun-Kyoung and Park, Gil-Chun and Namgoong, Jung-Man and Song, Gi-Won and Yoon, Young-In and Tak, Eunyoung and Lee, Sung-Gyu},
title = {Effects of combined immunosuppressant and hepatitis B virus antiviral use on COVID-19 vaccination in recipients of living donor liver transplantation},
journal = {PeerJ},
year = {2024},
doi = {10.7717/peerj.18651}
}
EUVIMED